11:49 AM EST - Pacgen Biopharmaceuticals Corp. : reported net loss for the first quarter of $209,000 or $0.01 per share, compared to a loss of $1.31 million or $0.04 per share in the year-ago quarter. Research and development expenses were $37,000, compared to $881,000 for the first quarter of 2009, primarily due to the reduced development activities following the comprehensive review in Fiscal 2009. Pacgen Biopharmaceuticals Corp.
shares V.PGA are trading even at $0.06.
